Purchasers Win Cert. Again In Blood Test Antitrust MDL

Law360, Los Angeles (October 19, 2015, 10:53 PM EDT) -- A Pennsylvania federal judge on Monday recertified a class of buyers of reagents used in blood tests in multidistrict litigation alleging that a former Johnson & Johnson unit conspired with another company to fix prices on the reagents.

U.S. District Judge Jan E. DuBois decided that an expert’s methodologies for calculating classwide damages survived a Daubert analysis because he had reliably estimated the alleged overcharge in a supposed scheme between former J&J unit Ortho-Clinical Diagnostics Inc. — now owned by the Carlyle Group — and Immucor...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.